Phospholipase Inhibitors

General description Recombinant, mouse MAP Kinase 2 expressed in E. coli .

Fosciclopirox suppresses growth of urothelial cancer by targeting the γ-secretase complex. Fosciclopirox selectively delivers the active metabolite, Ciclopirox (CPX), to the entire urinary tract. Ciclopirox has anticancer activity in a number of

Fosciclopirox suppresses growth of urothelial cancer by targeting the γ-secretase complex. Fosciclopirox selectively delivers the active metabolite, Ciclopirox (CPX), to the entire urinary tract. Ciclopirox has anticancer activity in a number of

Fosciclopirox suppresses growth of urothelial cancer by targeting the γ-secretase complex. Fosciclopirox selectively delivers the active metabolite, Ciclopirox (CPX), to the entire urinary tract. Ciclopirox has anticancer activity in a number of

Fosciclopirox suppresses growth of urothelial cancer by targeting the γ-secretase complex. Fosciclopirox selectively delivers the active metabolite, Ciclopirox (CPX), to the entire urinary tract. Ciclopirox has anticancer activity in a number of

Fosciclopirox suppresses growth of urothelial cancer by targeting the γ-secretase complex. Fosciclopirox selectively delivers the active metabolite, Ciclopirox (CPX), to the entire urinary tract. Ciclopirox has anticancer activity in a number of

FTY720 (R)-Phosphate, FTY720 is a novel immune modulator that inhibits lymphocyte emigration from lymphoid organs, which prolongs allograft transplant survival in numerous models. Sphingosine kinases phosphorylate FTYS20 in vivo so that FTYS20 acts

FTY720 (R)-Phosphate, FTY720 is a novel immune modulator that inhibits lymphocyte emigration from lymphoid organs, which prolongs allograft transplant survival in numerous models. Sphingosine kinases phosphorylate FTYS20 in vivo so that FTYS20 acts

GK187 is a potent and selective Group VIA calcium-independent phospholipase A 2 (GVIA iPLA 2 ) inhibitor with an X I (50) value of 0.0001. GK187 can be used for researching various neurological disorders [The X I (50) is the mole fraction of the

GK187 is a potent and selective Group VIA calcium-independent phospholipase A 2 (GVIA iPLA 2 ) inhibitor with an X I (50) value of 0.0001. GK187 can be used for researching various neurological disorders [The X I (50) is the mole fraction of the

GK187 is a potent and selective Group VIA calcium-independent phospholipase A 2 (GVIA iPLA 2 ) inhibitor with an X I (50) value of 0.0001. GK187 can be used for researching various neurological disorders [The X I (50) is the mole fraction of the

GK187 is a potent and selective Group VIA calcium-independent phospholipase A 2 (GVIA iPLA 2 ) inhibitor with an X I (50) value of 0.0001. GK187 can be used for researching various neurological disorders [The X I (50) is the mole fraction of the